J.A. Gevers Leuven

2.9k citations

69 papers · 2.4k indexed · h-index 27

Surgery top 2%
Endocrinology, Diabetes and Metabolism top 1%
Molecular Biology
Cardiology and Cardiovascular Medicine top 5%
Cancer Research top 5%

Co-authors: H.J.M. Kempen Louis M. Havekes Arnoud van der Laarse H.A. van der Voort Jan F. C. Glatz Mira Katan Anton F. H. Stalenhoef H. M. J. Krans
Topics: Lipoproteins and Cardiovascular Health (32 papers)Diabetes, Cardiovascular Risks, and Lipoproteins (18 papers)Cancer, Lipids, and Metabolism (13 papers)
Cited by: Endocrinology, Diabetes and Metabolism Biochemistry Surgery
Journals: The Lancet Journal of Clinical Investigation Advanced Functional Materials
Partner nations: Netherlands United Kingdom Sweden

In The Last Decade

J.A. Gevers Leuven

67 papers receiving 2.3k citations

Peers

Countries citing papers authored by J.A. Gevers Leuven

Since Specialization

Citations

This map shows the geographic impact of J.A. Gevers Leuven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.A. Gevers Leuven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.A. Gevers Leuven more than expected).

Fields of papers citing papers by J.A. Gevers Leuven

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.A. Gevers Leuven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.A. Gevers Leuven. The network helps show where J.A. Gevers Leuven may publish in the future.

Co-authorship network of co-authors of J.A. Gevers Leuven

This figure shows the co-authorship network connecting the top 25 collaborators of J.A. Gevers Leuven. A scholar is included among the top collaborators of J.A. Gevers Leuven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.A. Gevers Leuven. J.A. Gevers Leuven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cardiovascular disease and mortality in statin-treated patients with familial hypercholesterolemia 2004 ·Atherosclerosis ·Martina F Mohrschladt,Rudi G. J. Westendorp,J.A. Gevers Leuven,August H. M. Smelt	42
2	Genetic Analysis of Indicators of Cholesterol Synthesis and Absorption: Lathosterol and Phytosterols in Dutch Twins and Their Parents 2003 ·Twin Research ·Dorret I. Boomsma,P. Hans,Rune R. Frants,J.A. Gevers Leuven,(unknown)	15
3	The effect of tibolone on the lipoprotein profile of postmenopausal women with type III hyperlipoproteinemia 2002 ·Journal of Internal Medicine ·(unknown),August H. M. Smelt,(unknown),Nicoline Hoogerbrugge,Louis M. Havekes,J.A. Gevers Leuven	4
4	The effect of 17β-oestradiol on variables of coagulation and fibrinolysis in postmenopausal women with type 2 diabetes mellitus 2002 ·Vascular Pharmacology ·(unknown),J.A. Gevers Leuven,H. Michiel J. Krans,Cornelis Kluft	14
5	Bezafibrate reduces heart rate and blood pressure in patients with hypertriglyceridemia 2001 ·Journal of Hypertension ·I.J.A.M. Jonkers,(unknown),Arnoud van der Laarse,Marijke Frölich,J.A. Gevers Leuven,Ad Kamper,Gerard J. Blauw,A.H.M. Smelt	35
6	The hypolipidemic action of bezafibrate therapy in hypertriglyceridemia is mediated by upregulation of lipoprotein lipase: no effects on VLDL substrate affinity to lipolysis or LDL receptor binding 2000 ·Atherosclerosis ·Frits H.A.F. de Man,(unknown),Arnoud van der Laarse,Hans Jansen,J.A. Gevers Leuven,John H. M. Souverijn,(unknown),(unknown),Jean‐Charles Fruchart,Louis M. Havekes,A.H.M. Smelt	16
7	Similar response to simvastatin in patients heterozygous for familial hypercholesterolemia with mRNA negative and mRNA positive mutations 1998 ·Atherosclerosis ·Eric J.G. Sijbrands,Maria Lombardi,Rudi G. J. Westendorp,J.A. Gevers Leuven,A. Edo Meinders,Arnoud van der Laarse,Rune R. Frants,Louis M. Havekes,A.H.M. Smelt	36
8	Lifestyle, fibrinolysis and lipids. 1997 ·Pharmacy World & Science ·E.J.P. Brommer,J.A. Gevers Leuven,Pieter Brakman	2
9	Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM 1997 ·Diabetologia ·(unknown),J.A. Gevers Leuven,Michael A. Frölich,Cornelis Kluft,H. M. J. Krans	168
10	The T705I mutation of the low density lipoprotein receptor gene (FH Paris-9) does not cause familial hypercholesterolemia 1996 ·Human Genetics ·Pietro Lombardi,Eric J.G. Sijbrands,Sylvia W.A. Kamerling,J.A. Gevers Leuven,Louis M. Havekes	26
11	Hormone replacement therapy: a useful tool in the prevention of coronary artery disease in postmenopausal women? 1996 ·European Heart Journal ·C. J. Moerman,J. C. M. Witteman,H.J.A. Collette,J.A. Gevers Leuven,C. Kluft,Peter Kenemans,K Meeter	8
12	Effect of apolipoprotein E and insulin resistance on VLDL particles in combined hyperlipidemic patients 1996 ·Atherosclerosis ·Eric J.G. Sijbrands,Rudi G. J. Westendorp,Mariëtte J.V. Hoffer,Rune R. Frants,A. Edo Meinders,John H. M. Souverijn,J.A. Gevers Leuven,Arnoud van der Laarse,Louis M. Havekes,A.H.M. Smelt	5
13	Triglyceride-rich lipoproteins of subjects heterozygous for apolipoprotein E2(Lysl46→Gln) are inefficiently converted to cholesterol-rich lipoproteins 1994 ·Atherosclerosis ·Monique Mulder,Hans van der Boom,Peter de Knijff,(unknown),Arn M. J. M. van den Maagdenberg,J.A. Gevers Leuven,Louis M. Havekes	15
14	Diverse effects of the Dutch guidelines for a healthy diet on serum lipids of male patients with type IIA and type IIB hyperlipoproteinemia 1993 ·European Journal of Internal Medicine ·(unknown),(unknown),Christian Dina,J.A. Gevers Leuven,Arnoud van der Laarse,A.H.M. Smelt	4
15	Familial dysbetalipoproteinemia associated with apolipoprotein E3-Leiden in an extended multigeneration pedigree. 1991 ·Journal of Clinical Investigation ·Peter de Knijff,Arn M. J. M. van den Maagdenberg,A.F.H. Stalenhoef,J.A. Gevers Leuven,Pierre N.M. Demacker,L. P. Kuyt,Rune R. Frants,Louis M. Havekes	84
16	Effect of simvastatin on the apparent size of LDL particles in patients with type IIB hyperlipoproteinemia 1991 ·Clinica Chimica Acta ·(unknown),L. Hollaar,(unknown),A.H.M. Smelt,J.A. Gevers Leuven,Arnoud van der Laarse	23
17	Plasma levels of lathosterol and phytosterols in relation to age, sex, anthropometric parameters, plasma lipids, and apolipoprotein E phenotype, in 160 Dutch families 1991 ·Metabolism ·H.J.M. Kempen,Peter de Knijff,Dorret I. Boomsma,H.A. van der Voort,J.A. Gevers Leuven,(unknown)	56
18	Effects of oral contraceptives on lipid metabolism 1990 ·American Journal of Obstetrics and Gynecology ·J.A. Gevers Leuven,(unknown),Frans M. Helmerhorst,Rinse de Boer,(unknown),Louis M. Havekes	8
19	Apolipoprotein E3-Leiden allele results from a partial gene duplication in exon 4 1989 ·Biochemical and Biophysical Research Communications* ·Arn M. J. M. van den Maagdenberg,Peter de Knijff,A.F.H. Stalenhoef,J.A. Gevers Leuven,Louis M. Havekes,Rune R. Frants	48
20	Simvastatin (MK-733): a potent cholesterol synthesis inhibitor in heterozygous familial hypercholesterolaemia 1988 ·Atherosclerosis ·M.J.T.M. Mol,D. Willem Erkelens,J.A. Gevers Leuven,J. A. Schouten,Anton F. H. Stalenhoef	68

About J.A. Gevers Leuven

J.A. Gevers Leuven is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research and Surgery, having authored 69 papers that have together received 2.4k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (32 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (18 papers) and Cancer, Lipids, and Metabolism (13 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (851 citations), Biochemistry (222 citations) and Surgery (1.2k citations). J.A. Gevers Leuven has collaborated with scholars based in Netherlands, United Kingdom and Sweden. Frequent co-authors include H.J.M. Kempen, Louis M. Havekes, Arnoud van der Laarse, H.A. van der Voort, Jan F. C. Glatz, Mira Katan, Anton F. H. Stalenhoef, H. M. J. Krans, M.J.T.M. Mol and Cornelis Kluft. Their work appears in journals such as The Lancet, Journal of Clinical Investigation and Advanced Functional Materials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact